Drug price control: New list to be ready by January, says govt

Informing that 615 essential drugs have been brought under price control mechanism, government today told the Lok Sabha that the costs of medicines have reduced over the last six months and more steps
are in the offing to check prices.

Government said that by next month, it will come out with a new list of life-saving drugs whose prices would be controlled.

[caption id=“attachment_88279” align=“alignleft” width=“380”]  Representational image. Getty image. [/caption]Chemicals and Fertilisers Minister Ananth Kumar said since the new government came to power in May, 175 essential drugs have been added to the list of drugs which are under price control mechanism, taking the number to 615 as 440 were already covered under it.

New steps are being planned to check prices and increase availability of generic drugs, he said replying to a Calling Attention Motion.

In the motion, Congress members Ranjeet Ranjan and Susmita Dev accused the government of allowing substantial hike in essential drug prices, including those used for treating cancer, heart ailments, HIV and diabetes.

More from Economy

Inflation likely to be a big focus area for budget 2024, say sources Explained: Will the Bank of Japan break tradition and raise interest rates?

They attacked the government for the botched up sterlisation cases in Chhattisgarh which had claimed 17 lives recently, saying rise in drug prices as well as easy availability of spurious medicines were the major reasons for this.

To this, Health Minister JP Nadda promised stringent action to prevent such incidents in the future.

“(Medical) camps are not target-oriented but demand driven… (Following the Chhattisgarh incident) we have issued advisories and are reviewing their functioning to make such camps more effective,” he said.

While Kumar said 3,000 outlets to sell generic drugs would be opened across the country, Nadda said the government would come out by January with a new list of life-saving drugs whose prices would be controlled.

“In the last six months, the price of no drug or medicine has been hiked” and there is no question of prices skyrocketing, Kumar said, terming it as “misinformation campaign”.

“The aim of the government is to ensure good quality and affordable medicines for people,” he noted.

Participating in the debate, BJP member Varun Gandhi said that earlier price control regime had led to muted capital investments and lesser expenditure on research and development, which led to shortage of medicines.

When he claimed that drug prices have remained at almost same levels, Speaker Sumitra Mahajan told him, “The Minister will reply (to the debate). If you have seek clarification, you can ask.”

Responding to the discussion, Kumar refuted allegations that price of medicines have shot up in recent months. If at all something has happened, it is only that drug prices have come down under the Prime Minister Narendra Modi-led government, he claimed.

To keep a tab on price of drugs, government is conceptualising the idea of having ‘Price Monitoring Resource Unit’ in each state.

“This would be a progressive step,” Kumar said.

To ensure proper availability of generic drugs to common people, the government is planning to set up about 3,000 stores that would sell these medicines in different parts of the country.

In this regard, Kumar said he has already written to chief ministers and health ministers of states.

States can enter into a Memorandum of Understanding (MoU) with the Centre and the latter would help them in setting up generic drug stores.

“The plan is to have generic drugs store in every government hospital even at the district level,” Kumar said.

Nadda said the government would come out with an action programme to curb the menace of spurious drugs by increasing manpower, strengthening infrastructure and capacity of laboratories.

He also said a core committee under the Director General of the Indian Council for Medical Research (ICMR) will suggest a new list of medicines that can be brought under price control.

The list, likely to be ready by January, would be prepared after following scientific standards, he added.

PTI